Martha Q Lacy Selected Research

Multiple Myeloma

3/2024	Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
12/2023	Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
11/2023	Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
11/2023	Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
11/2023	Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma.
1/2023	Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.
1/2023	Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
1/2023	A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
11/2022	Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.
10/2022	Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martha Q Lacy Research Topics

Disease

123	Multiple Myeloma 03/2024 - 11/2002
87	Immunoglobulin Light-chain Amyloidosis 09/2023 - 03/2002
41	Amyloidosis 11/2022 - 01/2002
12	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 01/2002
11	Disease Progression 11/2023 - 07/2004
10	Neoplasms (Cancer) 01/2022 - 03/2007
10	Proteinuria 01/2022 - 01/2005
9	POEMS Syndrome (Syndrome, POEMS) 01/2022 - 04/2003
8	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2018 - 01/2002
6	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 02/2005
6	Smoldering Multiple Myeloma 01/2020 - 07/2004
4	Plasmacytoma 11/2023 - 04/2008
4	Trisomy (Trisomies) 12/2020 - 09/2005
4	Anemia 11/2020 - 01/2003
4	Monoclonal Gammopathy of Undetermined Significance 01/2020 - 07/2004
4	Thrombocytopenia (Thrombopenia) 12/2019 - 04/2006
4	Fever (Fevers) 01/2019 - 08/2011
4	Acute Kidney Injury (Acute Renal Failure) 06/2018 - 01/2005
3	Infections 01/2023 - 11/2002
3	Hypoalbuminemia 01/2022 - 01/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 07/2004
3	Albuminuria 12/2020 - 12/2012
3	Hypercalcemia (Milk Alkali Syndrome) 01/2020 - 01/2003
3	Renal Insufficiency (Renal Failure) 12/2019 - 06/2010
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 07/2004
2	Chromosome Aberrations (Chromosome Abnormalities) 11/2023 - 04/2011
2	Thrombosis (Thrombus) 01/2023 - 01/2022
2	Thrombocytosis (Thrombocythemia) 01/2022 - 05/2008
2	Vesicular Stomatitis 01/2022 - 01/2016
2	Plasma Cell Neoplasms 01/2020 - 06/2013
2	Measles 01/2019 - 07/2014
2	Cardiac Arrhythmias (Arrythmia) 10/2018 - 10/2016
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 09/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 09/2005
2	Lymphoma (Lymphomas) 01/2018 - 09/2017
2	Cardiotoxicity 02/2017 - 10/2010
2	Hemorrhage 01/2016 - 03/2003
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2015 - 09/2008
2	Scleromyxedema (Lichen Myxedematosus) 03/2015 - 10/2005
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2013 - 05/2008
2	Dyspnea (Shortness of Breath) 02/2013 - 08/2011
2	Exanthema (Rash) 01/2012 - 01/2007
2	Primary Myelofibrosis (Myelosclerosis) 04/2011 - 02/2010
2	Pain (Aches) 06/2010 - 08/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 04/2003

Drug/Important Bio-Agent (IBA)

26	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
20	Lenalidomide (CC 5013)FDA Link 03/2024 - 01/2007
20	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 07/2005
15	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2002
15	Immunoglobulin M (IgM)IBA 01/2021 - 01/2002
13	pomalidomideIBA 03/2021 - 10/2009
13	Thalidomide (Thalomid)FDA Link 10/2013 - 11/2002
12	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2003
10	Bortezomib (Velcade)FDA Link 01/2022 - 06/2013
9	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 11/2005
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2006
8	CreatinineIBA 12/2020 - 01/2002
7	Immunomodulating AgentsIBA 01/2022 - 10/2009
7	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 10/2010
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2010
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 09/2004
5	thiamine triphosphorate (TTP)IBA 11/2023 - 04/2003
5	Proteasome InhibitorsIBA 01/2022 - 11/2015
5	Troponin T (Troponin T1)IBA 01/2021 - 05/2007
5	Alkylating AgentsIBA 05/2012 - 03/2003
4	daratumumabIBA 12/2023 - 11/2017
4	Immunoglobulin G (IgG)IBA 01/2022 - 06/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
4	ixazomibIBA 01/2022 - 11/2016
4	Immunoglobulin A (IgA)IBA 01/2021 - 06/2010
4	AlbuminsIBA 12/2020 - 05/2007
4	Rituximab (Mabthera)FDA Link 08/2018 - 09/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 05/2007
3	Monoclonal AntibodiesIBA 01/2022 - 09/2006
3	TroponinIBA 06/2015 - 09/2004
3	DiureticsIBA 05/2007 - 01/2005
3	Serum AlbuminIBA 03/2007 - 11/2005
3	Indicators and Reagents (Reagents)IBA 09/2005 - 02/2003
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2020
2	venetoclaxIBA 01/2021 - 11/2020
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019 - 01/2019
2	VaccinesIBA 01/2019 - 12/2009
2	Congo RedIBA 11/2017 - 10/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 03/2007
2	C-Reactive ProteinIBA 01/2016 - 02/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014 - 07/2008
2	Prednisone (Sone)FDA LinkGeneric 02/2013 - 01/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2011 - 09/2010
2	Interleukin-1 (Interleukin 1)IBA 02/2009 - 02/2006

Therapy/Procedure

104	Therapeutics 03/2024 - 01/2002
68	Stem Cell Transplantation 11/2023 - 11/2002
18	Drug Therapy (Chemotherapy) 01/2018 - 11/2002
11	Hematopoietic Stem Cell Transplantation 03/2021 - 03/2004
10	Transplantation 10/2022 - 03/2003
9	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2012 - 01/2002
4	Kidney Transplantation 01/2022 - 07/2005
4	Aftercare (After-Treatment) 01/2021 - 05/2007
3	Autologous Transplantation 01/2017 - 12/2009
2	Hematopoietic Stem Cell Mobilization 01/2018 - 11/2005